TrialCardiovascular diabetology2025

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial.

Mohammad Abdel Jawad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.